Detalhe da pesquisa
1.
Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding.
Cell
; 176(1-2): 98-112.e14, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30633912
2.
The metastatic spread of breast cancer accelerates during sleep.
Nature
; 607(7917): 156-162, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732738
3.
Neutrophils escort circulating tumour cells to enable cell cycle progression.
Nature
; 566(7745): 553-557, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728496
4.
High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma.
Gynecol Oncol
; 174: 182-189, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210928
5.
Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
World J Surg Oncol
; 21(1): 40, 2023 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36755294
6.
Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.
BMC Cancer
; 22(1): 508, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524184
7.
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
Gynecol Oncol
; 166(3): 494-502, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35851489
8.
The double S technique to achieve aesthetic flat closure after conventional mastectomy.
World J Surg Oncol
; 20(1): 42, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189907
9.
Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment.
Int J Mol Sci
; 23(22)2022 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430718
10.
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Mol Cell Proteomics
; 18(9): 1836-1850, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289117
11.
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Gynecol Oncol
; 156(2): 377-386, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753525
12.
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
Gynecol Oncol
; 155(2): 262-269, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31604666
13.
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
Breast Cancer Res
; 20(1): 141, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458879
14.
MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells.
Gynecol Oncol
; 145(1): 159-166, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28214016
15.
Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting.
Int J Gynecol Cancer
; 26(6): 1062-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27177281
16.
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
Mol Cell Proteomics
; 13(9): 2213-32, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855066
17.
Long-term quality of life, satisfaction, pelvic floor symptoms and regret after colpocleisis.
Arch Gynecol Obstet
; 294(5): 999-1003, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27460073
18.
Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.
Gynecol Oncol
; 138(2): 363-71, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26080289
19.
Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.
BMC Mol Biol
; 15: 24, 2014 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294702
20.
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.
Cancer Immunol Immunother
; 63(9): 925-38, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24906866